Health in Timor-Leste, Democratic Republic of

968 indicators covering health for Timor-Leste, Democratic Republic of.

IndicatorLatest Year10-yr change Rank
Reported number of human rabies deaths 2 2024 β€” 42nd
Number of non-autochthonous leprosy cases 0 2024 β€” 47th
Prevalence of wasting, weight for height, female 6.6% 2020 down 61.8% 22nd
Prevalence of wasting, weight for height, male 9.9% 2020 down 51.5% 15th
Population with basic handwashing facilities at home 21.9% 2020 unchanged 80th
Prevalence of severe wasting, weight for height, female 1.1% 2020 down 84.1% 29th
Prevalence of severe wasting, weight for height, male 1.8% 2020 down 78.3% 23rd
Prevalence of overweight, weight for height, female 1.3% 2020 down 77.2% 78th
Prevalence of overweight, weight for height, male 1.2% 2020 down 79.7% 82nd
Prevalence of underweight, weight for age, female 30.2% 2020 down 30.6% 4th
Prevalence of underweight, weight for age, male 33.4% 2020 down 27.9% 3rd
Prevalence of stunting, height for age, female 44.7% 2020 down 19.6% 5th
Prevalence of stunting, height for age, male 48.6% 2020 down 18.3% 4th
How many health warnings are approved by the law for cigarette 6 2022 up 20.0% 85th
Tuberculosis - new and relapse cases 4,386 2011 up 58.9% 84th
Pregnant women receiving prenatal care 84.4% 2016 up 39.5% 80th
Generalist medical practitioners 937 2020 up 171.6% 82nd
Average of 13 International Health Regulations core capacity scores 73 2017 up 97.3% 89th
New cases: pulmonary smear-negative 1,823 2012 up 55.1% 59th
Average death rate due to natural disasters 0.3266 2016 down 53.6% 71st
Number of full-time equivalent staff in national agency 1 2022 unchanged 109th
Total number of notified TB cases 3,778 2014 up 1.1% 90th
New cases: pulmonary smear unknown/not done 0 2012 β€” 109th
Smear-positive tuberculosis treatment-success rate 91.0% 2011 up 12.3% 25th
How many health warnings are approved by the law for other smoked 6 2022 up 20.0% 77th
Insufficiently active 89.37 2016 up 0.3% 5th
Medical doctors 43.5% 2020 down 28.2% 62nd
Number of presumed malaria cases 0 2024 β€” 40th
Number of indigenous malaria cases 0 2024 down 100.0% 82nd
Number of confirmed malaria cases 1 2024 down 98.8% 98th
Total number ofΒ  malaria cases 1 2024 down 98.8% 98th
Retreatment cases: treatment after default 5 2012 down 72.2% 109th
Number of indigenous P. falciparum malaria cases 0 2024 down 100.0% 75th
Number of suspected malaria cases 177,056 2024 up 95.0% 72nd
Retreatment cases: other 0 2011 β€” 123rd
Retreatment cases: treatment after failure 4 2012 down 50.0% 107th
Number of malaria positive cases by microscopy 0 2024 β€” 93rd
Unmet need for contraception 25.3% 2016 down 19.7% 8th
Number of malaria suspects examined by microscopy 43,219 2024 β€” 72nd
Domestic Expenditure on Malaria 682,230 2024 down 32.8% 53rd
Exclusive breastfeeding 65.0% 2020 up 28.0% 8th
Laboratories providing tuberculosis diagnostic services using culture 0 2013 β€” 141st
Number of malaria positive cases by rapid diagnostic test 1 2024 down 98.8% 81st
Laboratories providing tuberculosis diagnostic services using sputum 1.6 2014 down 23.8% 51st
Number of malaria suspects examined by rapid diagnostic test 133,837 2024 up 47.4% 58th
Average cost of tuberculosis treatment multi drug resistant 50,471 2024 up 3,960.4% 2nd
Participation rate in organized learning (one year before the) 33.1% 2017 β€” 101st
Confirmed cases of MDR-TB 3 2012 β€” 111th
New cases: other 0 2012 β€” 33rd
Compliance with international health regulations 66 2016 up 78.4% 102nd
Number of malaria cases treated with any firstΒ  line tx courses 9 2023 down 70.0% 75th
Number of indigenous P. vivax malaria cases 0 2024 down 100.0% 39th
Number of imported malaria cases 1 2024 down 90.0% 53rd
Number of malaria cases treated with artemisinin-based combination 9 2023 down 70.0% 70th
Number of people protected from malaria by indoor residual spraying 68,363 2023 down 26.5% 41st
Exclusive breastfeeding under six months 65 2020 up 28.0% 6th
Exclusive breastfeeding under six months 10.68 2020 up 32.7% 62nd
Persistence to last grade of primary 83.0% 2017 down 0.7% 73rd
Pharmaceutical Technicians and Assistants 160 2015 up 1,130.8% 38th
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) 100.0% 2014 unchanged 1st